Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
JM Keppel Hesselink, DJ Kopsky - Journal of pain research, 2015 - Taylor & Francis
Palmitoylethanolamide (PEA) is an endogenous lipid modulator in animals and humans,
and has been evaluated since the 1970s as an anti-inflammatory and analgesic drug in …
and has been evaluated since the 1970s as an anti-inflammatory and analgesic drug in …
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β‐cells
I Matias, MP Gonthier, S Petrosino… - British journal of …, 2007 - Wiley Online Library
The endocannabinoid, arachidonoylethanolamide (AEA), and the peroxisome proliferator‐
activated receptor (PPAR)‐α ligand, oleylethanolamide (OEA) produce opposite effects on …
activated receptor (PPAR)‐α ligand, oleylethanolamide (OEA) produce opposite effects on …
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
C Solorzano, C Zhu, N Battista… - Proceedings of the …, 2009 - National Acad Sciences
Identifying points of control in inflammation is essential to discovering safe and effective
antiinflammatory medicines. Palmitoylethanolamide (PEA) is a naturally occurring lipid …
antiinflammatory medicines. Palmitoylethanolamide (PEA) is a naturally occurring lipid …
Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis
A Gatti, M Lazzari, V Gianfelice, A Di Paolo… - Pain …, 2012 - academic.oup.com
Objective. To assess the efficacy and safety of palmitoylethanolamide (PEA), an
endogenous fatty acid amide belonging to the N-acylethanolamines family, in reducing pain …
endogenous fatty acid amide belonging to the N-acylethanolamines family, in reducing pain …
[HTML][HTML] Palmitoylethanolamide counteracts enteric inflammation and bowel motor dysfunctions in a mouse model of Alzheimer's disease
V D'Antongiovanni, C Pellegrini, L Antonioli… - Frontiers in …, 2021 - frontiersin.org
Palmitoylethanolamide (PEA), an endogenous lipid mediator, is emerging as a promising
pharmacological agent in multiple neurodegenerative disorders for its anti-inflammatory and …
pharmacological agent in multiple neurodegenerative disorders for its anti-inflammatory and …
[HTML][HTML] Palmitoylethanolamide in the treatment of chronic pain: a systematic review and meta-analysis of double-blind randomized controlled trials
K Lang-Illievich, C Klivinyi, C Lasser, CTA Brenna… - Nutrients, 2023 - mdpi.com
Chronic pain is a major source of morbidity for which there are limited effective treatments.
Palmitoylethanolamide (PEA), a naturally occurring fatty acid amide, has demonstrated utility …
Palmitoylethanolamide (PEA), a naturally occurring fatty acid amide, has demonstrated utility …
2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation
D Impellizzeri, M Cordaro, G Bruschetta, R Crupi… - Pharmacological …, 2016 - Elsevier
N-acylethanolamines (NAEs) comprise a family of bioactive lipid molecules present in
animal and plant tissues, with N-palmitoylethanolamine (PEA) having received much …
animal and plant tissues, with N-palmitoylethanolamine (PEA) having received much …
Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-alpha
M Koch, S Kreutz, C Böttger, A Benz, E Maronde… - Neurotoxicity …, 2011 - Springer
Endocannabinoids like 2-arachidonoylglycerol strongly modulate the complex machinery of
secondary neuronal damage and are shown to improve neuronal survival after excitotoxic …
secondary neuronal damage and are shown to improve neuronal survival after excitotoxic …
The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson's disease model
R Siracusa, I Paterniti, D Impellizzeri… - CNS & Neurological …, 2015 - ingentaconnect.com
Parkinson's disease (PD) is a disorder resulted by degeneration of dopaminergic neurons.
To counteract the neuroinflammation and oxidative stress of PD, we decided to test a new …
To counteract the neuroinflammation and oxidative stress of PD, we decided to test a new …
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation
I Paterniti, M Cordaro, M Campolo… - CNS & Neurological …, 2014 - ingentaconnect.com
Alzheimer's disease (AD) is the most common neurodegenerative disorder. Its
neuropathological hallmarks include deposition of beta amyloid (Aβ) fibrils in senile …
neuropathological hallmarks include deposition of beta amyloid (Aβ) fibrils in senile …